BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Anticholium® (physostigmine salicylate): change in the approval

Active substance: physostigmine salicylate

Dr. Franz Köhler Chemie GmbH informs about the change in the approval of Anticholium®. The intramuscular application is no longer approved. Anticholium® is now sodium metabisulfite free.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 158KB, File is accessible